• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

正常男性和性腺功能减退男性口服十一酸睾酮后的唾液和血清睾酮水平

Saliva and serum testosterone following oral testosterone undecanoate administration in normal and hypogonadal men.

作者信息

Schürmeyer T, Wickings E J, Freischem C W, Nieschlag E

出版信息

Acta Endocrinol (Copenh). 1983 Mar;102(3):456-62. doi: 10.1530/acta.0.1020456.

DOI:10.1530/acta.0.1020456
PMID:6402875
Abstract

Since saliva testosterone reflects the testosterone fraction available to target tissues the therapeutic effectiveness of orally administered testosterone undecanoate was assessed by measuring testosterone in serum and saliva. Matched saliva and serum samples were obtained from 12 normal men and 8 hypogonadal men before and at hourly intervals after the oral administration of 120 mg testosterone undecanoate. The test was repeated in 3 men after they had taken 40 mg testosterone undecanoate twice daily for 4 to 5 weeks. Following testosterone undecanoate administration serum and saliva testosterone always showed parallel increases. However, the absorption curves showed a high interindividual variability in the time when maximum concentrations were reached, as well as in the maximum levels themselves. The increases in serum and saliva testosterone were similar in normal and hypogonadal men. In normal men basal levels were reached 4 h after the maximum had occurred, while in hypogonadal men testosterone levels were not different from basal levels 2 h after the maximum. The study shows that testosterone undecanoate is well absorbed from the gut and releases significantly elevated amounts of testosterone which is available to target tissues. As the absorption pattern was always parallel in both fluids, hydrolysis of the circulating testosterone ester by the tissue itself seems to effect no additional increase of testosterone in the tissue.

摘要

由于唾液睾酮反映了靶组织可利用的睾酮部分,因此通过测量血清和唾液中的睾酮来评估口服十一酸睾酮的治疗效果。在12名正常男性和8名性腺功能减退男性口服120mg十一酸睾酮之前及之后,每隔一小时采集配对的唾液和血清样本。在3名男性每天两次服用40mg十一酸睾酮,持续4至5周后重复该试验。服用十一酸睾酮后,血清和唾液睾酮始终呈平行升高。然而,吸收曲线显示,达到最大浓度的时间以及最大浓度本身存在高度个体间差异。正常男性和性腺功能减退男性的血清和唾液睾酮升高情况相似。在正常男性中,最大值出现后4小时达到基础水平,而在性腺功能减退男性中,最大值出现后2小时睾酮水平与基础水平无差异。该研究表明,十一酸睾酮从肠道吸收良好,释放出显著升高的可被靶组织利用的睾酮量。由于两种体液中的吸收模式始终平行,循环中的睾酮酯被组织自身水解似乎不会导致组织中睾酮的额外增加。

相似文献

1
Saliva and serum testosterone following oral testosterone undecanoate administration in normal and hypogonadal men.正常男性和性腺功能减退男性口服十一酸睾酮后的唾液和血清睾酮水平
Acta Endocrinol (Copenh). 1983 Mar;102(3):456-62. doi: 10.1530/acta.0.1020456.
2
A pharmacokinetic study of injectable testosterone undecanoate in hypogonadal men.十一酸睾酮注射液在性腺功能减退男性中的药代动力学研究。
J Androl. 1998 Nov-Dec;19(6):761-8.
3
Hypogonadal men treated with oral testosterone undecanoate.
Acta Eur Fertil. 1977 Dec;8(4):297-9.
4
Treatment of male hypogonadism with testosterone undecanoate injected at extended intervals of 12 weeks: a phase II study.以12周的延长间隔注射十一酸睾酮治疗男性性腺功能减退:一项II期研究。
J Androl. 2002 May-Jun;23(3):419-25.
5
Basal and LHRH-stimulated gonadotropin levels and the circadian rhythm of testosterone and the effect of exogenous testosterone thereon.基础及促性腺激素释放激素刺激后的促性腺激素水平、睾酮的昼夜节律及其对外源性睾酮的反应。
Andrologia. 1984 May-Jun;16(3):249-55. doi: 10.1111/j.1439-0272.1984.tb00276.x.
6
Clinical and hormonal effects of testosterone undecanoate (TU) in male sexual impotence.
Endocrinologie. 1982 Oct-Dec;20(4):289-93.
7
A time-resolved fluorescence immunoassay for the measurement of testosterone in saliva: monitoring of testosterone replacement therapy with testosterone buciclate.一种用于测量唾液中睾酮的时间分辨荧光免疫测定法:用布西睾酮监测睾酮替代疗法。
Clin Chem Lab Med. 1998 Apr;36(4):223-30. doi: 10.1515/CCLM.1998.038.
8
Repeated intramuscular injections of testosterone undecanoate for substitution therapy in hypogonadal men.在性腺功能减退男性中,重复肌肉注射十一酸睾酮进行替代治疗。
Clin Endocrinol (Oxf). 1999 Dec;51(6):757-63. doi: 10.1046/j.1365-2265.1999.00881.x.
9
Urine and Serum Sex Steroid Profile in Testosterone-Treated Transgender and Hypogonadal and Healthy Control Men.睾酮治疗的跨性别者、性腺功能减退症患者和健康对照男性的尿液和血清性激素谱。
J Clin Endocrinol Metab. 2018 Jun 1;103(6):2277-2283. doi: 10.1210/jc.2018-00054.
10
Dietary fat modulates the testosterone pharmacokinetics of a new self-emulsifying formulation of oral testosterone undecanoate in hypogonadal men.膳食脂肪可调节性腺功能减退男性口服十一酸睾酮新型自乳化制剂的睾酮药代动力学。
J Androl. 2012 Nov-Dec;33(6):1282-90. doi: 10.2164/jandrol.112.017020. Epub 2012 Jul 12.

引用本文的文献

1
Testosterone Replacement Therapy: A Narrative Review with a Focus on New Oral Formulations.睾酮替代疗法:一篇侧重于新型口服制剂的叙述性综述。
touchREV Endocrinol. 2022 Nov;18(2):133-140. doi: 10.17925/EE.2022.18.2.133. Epub 2022 Aug 24.
2
The novel BRDT inhibitor NHWD870 shows potential as a male contraceptive in mice.新型 BRDT 抑制剂 NHWD870 有望成为雄性避孕药在小鼠中。
Acta Biochim Biophys Sin (Shanghai). 2022 Sep 25;54(12):1789-1800. doi: 10.3724/abbs.2022135.
3
An oral lipidic native testosterone formulation that is absorbed independent of food.
一种口服脂溶性天然睾酮制剂,不受食物影响而被吸收。
Eur J Endocrinol. 2021 Oct 5;185(5):607-615. doi: 10.1530/EJE-21-0606.
4
Accurate measurement of androgen after androgen esters: problems created by ex vivo esterase effects and LC-MS/MS interference.雄激素酯后雄激素的准确测量:体外酯酶作用和 LC-MS/MS 干扰造成的问题。
Andrology. 2019 Jan;7(1):42-52. doi: 10.1111/andr.12554. Epub 2018 Oct 21.
5
Corrigendum to "Validation of a testosterone and dihydrotestosterone liquid chromatography tandem mass spectrometry assay: interference and comparison with established methods" [Steroids Volume 73, Issue 13, 12 December 2008, Pages 1345-1352].《睾酮和双氢睾酮液相色谱串联质谱分析法的验证:干扰及与现有方法的比较》勘误 [《类固醇》第73卷,第13期,2008年12月12日,第1345 - 1352页]
Steroids. 2018 Jul;135:108. doi: 10.1016/j.steroids.2018.05.006.
6
Population Pharmacokinetic/Pharmacodynamic Modeling of Depot Testosterone Cypionate in Healthy Male Subjects.健康男性受试者中睾酮 Cypionate 注射液的群体药代动力学/药效学建模。
CPT Pharmacometrics Syst Pharmacol. 2018 Apr;7(4):259-268. doi: 10.1002/psp4.12287. Epub 2018 Mar 1.
7
The potential role of oral fluid in antidoping testing.唾液在反兴奋剂检测中的潜在作用。
Clin Chem. 2014 Feb;60(2):307-22. doi: 10.1373/clinchem.2013.209676. Epub 2013 Oct 23.
8
Validation of a testosterone and dihydrotestosterone liquid chromatography tandem mass spectrometry assay: Interference and comparison with established methods.睾酮和双氢睾酮液相色谱串联质谱分析法的验证:干扰及与既定方法的比较。
Steroids. 2008 Dec 12;73(13):1345-52. doi: 10.1016/j.steroids.2008.05.004. Epub 2008 May 21.
9
Testosterone for the aging male; current evidence and recommended practice.老年男性的睾酮;当前证据与推荐做法。
Clin Interv Aging. 2008;3(1):25-44. doi: 10.2147/cia.s190.
10
A new oral testosterone undecanoate formulation.一种新型口服十一酸睾酮制剂。
World J Urol. 2003 Nov;21(5):311-5. doi: 10.1007/s00345-003-0372-x. Epub 2003 Oct 25.